 |
|
| Blog results | Results 1 - 10 of about 30,312 for clinical trial on irritable bowel syndrome. (0.68 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | CenterWatch: Clinical Trials Today - http://www.centerwatch.com/news-resources/clinical-trials-today/ Irritable Bowel Syndrome Blog - http://ibs.about.com/b/ On Biostatistics and Clinical Trials - http://onbiostatistics.blogspot.com/ Kerr Lab - Publications - http://www.dogpod.com/projects/kerr_lab/blogengine/publicationsblog/pubblog.html | |
| 5 Dec 2009 Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett. ... Suite101: Health & Wellness Articles - http://www.suite101.com/healthandwellness/ [ More results from Suite101: Health & Wellness Articles ] |
| 8 Nov 2009 Irritable Bowel Syndrome (IBS) with Constipation - Lakewood WA (Clinical Trial 6494) Permalink: http://www.ClinicalConnection.com/PatientViewStudy6494.aspx. ** Please review additional "Nearby Studies" on right -----> ... ClinicalConnection.com New Clinical Trials - http://www.clinicalconnection.com/NewsWire.aspx [ More results from ClinicalConnection.com New Clinical Trials ] |
| 23 Nov 2009 Discovered and developed by Lexicon, LX1031 is the first TPH inhibitor ever to be evaluated in human clinical trials for the treatment of IBS. In Phase 1 clinical trials, all dose levels of the drug were well tolerated, ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html - References [ More results from Drugs.com - Clinical Trials ] |
| 5 Dec 2009 by Megan The first thing that will hit you about Bavolex is that it is formulated based on scientific studies as well as by using results of clinical trials as well as laboratory test results to formulate the best medication. Bavolex is an IBS ... MyTownTalks - http://www.mytowntalks.com/ [ More results from MyTownTalks ] |
| 2 Dec 2009 IBS with Constipation. This 16-week study will involve nine clinic visits, with the option to extend the study for a year. You must be 18 or older and have IBS with constipation to qualify. The research site is in Phoenix, Ariz. ... HealthDay - http://www.dentalplans.com/articles_rss/categoryrss104.xml [ More results from HealthDay ] |
| 13 Nov 2009 by AP Lexicon says IBS drug met mid-stage study goal. THE WOODLANDS, Texas — Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial. The company said patients who took ... Health News - http://blog.taragana.com/health/ [ More results from Health News ] |
| 13 Nov 2009 Irritable Bowel Syndrome (IBS) with Constipation. If you are 18 or older and have IBS with constipation, you may qualify for this study of an investigational medication. Qualified participants may be compensated up to $480 for time and ... DentalPlans.Com Articles - http://www.dentalplans.com/articles_rss/categoryrss0.xml |
| 3 Dec 2009 The manufacturers of Amitiza (lubiprostone) recently announced some positive results of ongoing studies into the safety and effectiveness of the medication as a treatment for constipation predominant IBS (IBS-C) and chronic idiopathic ... The medication was effective regardless of the age, gender or race of study participants; Symptom relief was experienced up to year (the length of the clinical trials); The medication helped those whose symptoms did not respond to any ... About.com Irritable Bowel Syndrome - http://ibs.about.com/b/ [ More results from About.com Irritable Bowel Syndrome ] |
| 23 Nov 2009 PPD, a global CRO, has entered an agreement with Janssen Pharmaceutica NV to develop and commercialize two phase II-ready therapeutic compounds, one to treat diarrhea-predominant irritable bowel syndrome (IBS-d) and the other to treat ... If Janssen does not buy back a program, PPD will have the option to continue developing and commercializing the compound for that program and Janssen will receive up to $250 million in clinical and sales milestones and royalties on sales ... CenterWatch Clinical Trials Today Headlines - http://www.centerwatch.com/news-resources/clinical-... |
| 3 Dec 2009 by Linda Delegates at the seminar, which focused on the potential of the Lactobacillus plantarum 299v strain, were agreed on the potential of probiotics to treat IBS, but acknowledged that more work is needed to develop effective treatment strategies. ... To help build a treatment consensus, Haddad said more in vivo clinical trials are needed in order to validate in vitro data. This will allow those promising strains that are most effective in alleviating abdominal pain and ... FIGHT for your health! - http://lymebook.com/fight/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
